News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

NANTKWEST (NK) Intrexon (XON) PTC Therapeutics (PTCT) Intercept (ICPT) Jazz Pharmaceuticals (JAZZ) Endometrial Cancer Bellicum (BLCM) Prolor Biotech (PBTH) AGOS (ARGS) Herceptin AstraZeneca (AZN) Array Pharmaceuticals (ARRY) Dendreon (DNDN) Sangamo (SGMO) Agenus (AGEN Intermune (ITMN) INNOVIVA (INVA) Roche (ROCHE) OSI (OSIP) galapagos (GLPG) SYNTA (SNTA) GUARDIAN HEALTH Merck (MRK) Onyx (ONXX) BIOMARIN (BMRN) JUNO (JUNO) ABBVIE (ABBV) ZALTRAP™ Inovio (INO) ARGOS (ARGS) Vertex (VRTX) IDERA (IDRA) Incyte (INCY) Sanofi-Aventis (SAN) Auspex (ASPX) Theravance Bio Pharma (TBPH) Sanofi (SNY) Multiple Myeloma Mirati Therapeutics (MRTX) Alder Biopharmaceuticals (ALDR) Dynavax (DVAX) Velcade (bortezomib) Illumina (ILMN) Benlysta (belimumab) Agenus (AGEN) Sanofi (SNA) Alnylam (ALNY) Seattle Genetics (SGEN) Vitae Pharmaceuticals (VTAE) Ziofpharm (ZIOP) ADVENTRIX (ANX) Elan (ELN) Pluristem (PSTI) Anadys (ANDS) Regeneron (REGN) Zerenex NEKTAR (NKTR)) Valeant Pharmaceuticals International (VRX) GlaxoSmithKline (GSK) ARCA (ABIO) SERES THERAPEUTICS (MCRB) RenenxBio (RGNX) Amgen (AMGN) CompuGen (CGEN) Genentech Adaptimmune (ADAP) VANDA (VNDA) NOVOCURE (NVCR) Ariad (ARIA) Abbott Laboratories (ABT) TOKAI (TKAOI) MODERNA Advaxis (ADXS) Global Cell Therapeutics (GBT) Micromet (MITI) Aimmune Therapeutics (AIMT) Roche (RHHBY) SUNESIS PHARMACEUTICALS (SNSS) Editas (EDIT) Idenix (IDIX) ImmunoGen (IMGN) Galena (GALE) Anacor (ANAC) Ionis (IONS) Trastuzumab-DM1 HALOZYME (HALO) Ridaforolimus Telaprevir Exelixis (EXEL) Biogen Idec (BIIB) KITE (KITE) Human Genome Sciences (HGSI) CRISPR Therapeutics (CRSP) ISIS (ISIS) Sequenom (SQNM) AERIE PHARMACEUTICALS Revlimid (lenolidamide) Biocryst (BCRX) Theravance (THRX) ACADIA (ACAD) KERYX (KERX) Prosensa (RNA) Human Longevity (HLI) Gilead (GILD) Rapamune C4 Therapeutics Tysabri Sarepta (SRPT) REGULUS (RGLS) Spike Therapeutics (ONCE) Xoma (XOMA) Cytokinetics (CYTK) Bristol-Myers Squibb (BMY)